BridgeBio Oncology Therapeutics (BBOT) Other Working Capital Changes (2025 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Other Working Capital Changes of -$123000.0 for Q1 2026, down 1.65% sequentially from -$121000.0 in Q4 2025.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Other Working Capital Changes (2025 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Other Working Capital Changes for 2 years, with the latest figure at -$123000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed N/A year-over-year to -$123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$244000.0 (changed N/A YoY) and the FY2025 annual result came in at -$47000.0, changed N/A from the prior year.
- Other Working Capital Changes retreated to -$123000.0 in Q1 2026 per BBOT's latest filing, from -$121000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at -$121000.0 in Q4 2025 and troughed at -$123000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | BridgeBio Oncology Therapeutics | 723.69 Mn | 497.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -129,000.00 |
| Jun 30, 2026 | -129,000.00 |
| Mar 31, 2026 | -123,000.00 |
| Mar 31, 2026 | -123,000.00 |
| Dec 31, 2025 | -121,000.00 |
| Dec 31, 2025 | -121,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |